Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

752468

registered interest
date	17/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Parkinson's Disease: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government how much the NHS pays for a one year supply of Apomorphine for a patient with Parkinson's Disease; how much they estimate it costs to manufacture a year's supply of that drug; what assessment they have made of the difficulties of manufacturing Apomorphine to clinical standards; and whether they intend to take any steps to reduce the cost of that drug to the NHS.
tabling member printed	Lord Lucas
uin	HL914
answer	answer is ministerial correction date of answer 19/07/2017 answer text <p>The drug cost to the National Health Service for a one year supply of Apomorphine for a patient with Parkinson's Disease is estimated to be in the region of £5,300 and £9,000, based on the usual daily dose of 3 – 30mg. However, the maximum daily is 100mg, so the annual cost for some patient’s treatment may be higher.</p><p>We have no estimate of the cost of manufacture. We are not aware of any particular issues relating to the manufacture of this drug. Pharmaceutical companies participate in either the voluntary pharmaceutical price regulation scheme (PPRS) or the statutory medicines price regulation scheme, both of which regulate the cost of medicines to the NHS. Products covered by the statutory scheme are subject to a 15% cut to their list price. Companies in the PPRS pay a percentage of sales to the Government when growth in NHS spending on medicines exceeds an agreed level. NHS purchasers may also negotiate discounts with pharmaceutical companies in addition to national price regulation.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 19/07/2017 15:12:09 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1879 label Biography information for Lord Lucas

752469

registered interest
date	17/07/2017
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what assessment they have made of the state of the dairy sector in England.
tabling member printed	Baroness McIntosh of Pickering
uin	HL915
answer	answer is ministerial correction date of answer 24/07/2017 answer text <p>The dairy sector in England is recovering after 2 years of low prices caused largely by global factors. The UK average farm-gate milk price for May 2017 is 26.78 pence per litre, which is 31% higher than the same month in 2016, but a little lower than in March and April. Production in May of 1322 million litres is around the same level as last year.</p><p> </p> answering member printed Lord Gardiner of Kimble question first answered 24/07/2017 10:36:57 answering member 4161 label Biography information for Lord Gardiner of Kimble
tabling member	384 label Biography information for Baroness McIntosh of Pickering

752479

registered interest
date	17/07/2017
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether, and how, the wider social costs and benefits of regulations are taken into account by Government departments in (1) achieving their policy objectives for the business impact target, (2) the implementation of the One in, Three out rule announced by the Business Secretary on 3 March 2016, and (3) the application of the requirement to identify £3 in savings for each £1 of additional cost when assessing proposed new regulations.
tabling member printed	Lord Rennard
uin	HL925
answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>HM Treasury’s Green Book guidance on policy appraisal and evaluation sets out how the economic, financial, social and environmental assessments of a policy, or specification of regulations, should be combined. The Government has not yet decided how its better regulation system will operate in this Parliament. This includes any One-In, Two-Out policy and the setting of a target in respect of the economic impact of new regulation on business for this Parliament as required under section 21 of the Small Business, Enterprise and Employment Act 2015.</p> answering member printed Lord Prior of Brampton question first answered 20/07/2017 15:20:10 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2484 label Biography information for Lord Rennard

752481

registered interest
date	17/07/2017
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether the Regulatory Policy Committee is empowered to rate an impact assessment as inadequate on the grounds that it does not adequately consider the wider social costs and benefits of proposed regulatory measures.
tabling member printed	Lord Rennard
uin	HL927
answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Regulatory Policy Committee (RPC) comments on the Government’s performance in assessing regulatory impacts as set out in Impact Assessments. These assessments should address the wider societal costs and benefits. The RPC sets out its view on the analysis contained in the impact assessments in its published Opinions and annual reports. Under its current remit, the RPC cannot rate an impact assessment as ‘not fit for purpose’ in relation to wider societal impacts at final stage. The Government has not yet decided what approach it will take to deliver better regulation during the current Parliament.</p> answering member printed Lord Prior of Brampton question first answered 20/07/2017 15:08:31 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2484 label Biography information for Lord Rennard

752482

registered interest
date	17/07/2017
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what estimates of (1) the value of lives saved, and (2) additional life years gained, they use when classifying proposed regulatory measures as “in”, “out” or “zero net cost” in departmental submissions to the Regulatory Policy Committee.
tabling member printed	Lord Rennard
uin	HL928
answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>HM Treasury’s Green Book guidance on policy appraisal and evaluation sets out how the economic, financial, social and environmental assessments of a policy, or specification of regulations, should be combined. It includes guidance on appraising social impacts, such as health and welfare benefits and prevented fatality and how to weight such considerations against other impacts.</p> answering member printed Lord Prior of Brampton question first answered 20/07/2017 15:09:34 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2484 label Biography information for Lord Rennard